• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GAO Tianqin,ZHANG Quanyi,MA Yibing,SUN Meijuan.Comparison of the efficacy of propofol respectively combined with fentanyl,dezocine and butorphanol for painless gastroscopy[J].Journal Of Pharmaceutical Research,2017,36(2):115-117[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3651times   Download 2555次 QR Code for this article
Scan with your phone!
丙泊酚复合芬太尼、地佐辛、布托啡诺用于无痛胃镜检查的疗效观察
高天勤1,张全意1,马译兵2,孙美娟1
Font:Larger+|Default|Smaller-
(1.滨州医学院附属医院,山东 滨州 256603;2.滨州经济技术开发区杜店街道社区卫生服务中心,山东 滨州 256603)
摘要:
目的 比较丙泊酚分别复合芬太尼、地佐辛、布托啡诺用于无痛胃镜检查的麻醉效果及安全性。方法 114例拟行无痛胃镜检查患者随机分为芬太尼组、地佐辛组和布托啡诺组,每组38例患者。所有患者检查前禁食8 h以上,禁水4 h以上,均无麻醉前用药。芬太尼组患者静脉推注芬太尼1 μg·kg-1;地佐辛组患者静脉推注地佐辛20 μg·kg-1;布托啡诺组患者静脉推注酒石酸布托啡诺组10 μg·kg-1。三组患者均在5 min后静脉推注2 mg·kg-1丙泊酚。观察各组患者收缩压(SBP)、舒张压(DBP)、心率(HR)及脉搏血氧饱和度(SpO2)值的变化情况,同时比较三组患者体动、呼吸抑制、苏醒时间、恶心呕吐和头晕情况。结果 与检查前比较,三组患者检查中时间点的各项指标均有所下降(P<0.05);与芬太尼组比较,检查中时间点地佐辛组的舒张压和布托啡诺组心率均有所降低(P<0.05),而检查后布托啡诺组心率又有所升高(P<0.05)。布托啡诺组患者苏醒时间明显短于其他两组患者。各组患者检查后均有出现恶心呕吐、头晕的不良反应,而布托啡诺组的发生率明显低于芬太尼组和地佐辛组(P<0.05)。结论 丙泊酚复合布托啡诺用于无痛胃镜检查的麻醉效果和安全性均比芬太尼、地佐辛好。
关键词:  胃镜检查  丙泊酚  芬太尼  地佐辛  布托啡诺  联合用药
DOI:10.13506/j.cnki.jpr.2017.02.015
基金项目:
Comparison of the efficacy of propofol respectively combined with fentanyl,dezocine and butorphanol for painless gastroscopy
GAO Tianqin1,ZHANG Quanyi1,MA Yibing2,SUN Meijuan1
(1.Binzhou Medical University Hospital,Binzhou 256603,China;2.Dudian Street Community Health Center of Binzhou Economic and Technological Development Zone,Binzhou 256603,China)
Abstract:
Objective To compare the efficacy of propofol respectively combined with fentanyl,dezocine and butorphanol for painless gastroscopy.Methods 114 cases of patients for painless gastroscopy were randomly divided into fentanyl group,dezocine group and butorphanol group,each group had 38 patients.All patients were fasted for 8 h and prohibited drink water for 4 h before examination,had no preanesthetic medication. Patients in fentanyl group were intravenous pushed fentanyl 1 μg·kg-1,patients in dezocine group were intravenous pushed dezocine 20 μg·kg-1,patients in butorphanol group were intravenous pushed butorphanol tartrate 10 μg·kg-1.All patients in 3 groups were intravenous pushed propofol 2 mg·kg-1 after 5 min.The changes of SBP,DBP,HR,SpO2 were observed,and the conditions of body movement,respiratory depression,wake up time,nausea and vomitting,dizzy were compared.Results Comparing with before check,each index of all patients on the time of in check were reduced(P<0.05).Comparing with fentanyl group,the DBP of fentanyl group and HR of butorphanol group on the time of in check was reduced(P<0.05).After check,the HR of butorphanol group was rised(P<0.05).The wake up time of butorphanol group was obviously shorter than other two groups.Nausea,vomiting and dizzy were appeared in each group,but the incidence rate in butorphanol group was obviously lower than fentanyl group and dezocine group(P<0.05).Conclusion The anesthesia effect and safety of propofol combined with butorphanol for painless gastroscopy was better than with fentanyl and dezocine.
Key words:  Gastroscopy  Propofol  Fentanyl  Dezocine  Butorphanol  Drug combination
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.